Regulatory mechanisms and clinical manifestations of musculoskeletal aging
Abstract
Aging is the strongest risk factor for degenerative bone and joint diseases. Clinical therapies for age‐related musculoskeletal disorders face significant challenges as their pathogenic mechanisms remain largely unclear. This review article focuses on the recent advances in the understanding of regulatory mechanisms of musculoskeletal aging and their clinical relevance. We begin with the prevalence and socioeconomic impacts of major age‐related musculoskeletal disorders such as sarcopenia, osteoporosis, osteoarthritis, and degenerative tendinopathy. The current understanding of responsible biological mechanisms involved in general aging is then summarized. Proposed molecular, cellular, and biomechanical mechanisms relevant to the clinical manifestations of aging in the musculoskeletal system are discussed in detail, with a focus on the disorders affecting muscle, bone, articular cartilage, and tendon. Although musculoskeletal aging processes share many common pathways with the aging of other body systems, unique molecular and cellular mechanisms may be involved in the aging processes of musculoskeletal tissues. Advancements in the understanding of regulatory mechanisms of musculoskeletal aging may promote the development of novel treatments for age‐related musculoskeletal disorders. Finally, future research directions for major musculoskeletal tissues including functional interaction between the tissues and their clinical relevance to age‐related musculoskeletal disorders are highlighted in the Future Prospects section. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:1475–1488, 2019.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 03, 2019
- Source ID
- 10.1002/jor.24292
Entities
People
- Caleb Grote
- Daniel Reinhardt
- Jinxi Wang
- Mingcai Zhang
Organizations
- National Institutes of Health
- United States Department of Defense
- University of Kansas